FDA AND GLOBAL REGULATORY INSPECTION EXPECTATIONS FOR CPV

by
Continued Process Verification (CPV) dashboard showing pharmaceutical manufacturing process monitoring and statistical trend analysis.

FDA and Global Regulatory Inspection Expectations for CPV Regulatory authorities expect Continued Process Verification (CPV) to be an integral part of the Pharmaceutical Quality System (PQS). During inspections, investigators typically evaluate whether manufacturers have established a scientifically justified and risk-based program to continuously monitor commercial manufacturing processes. Inspectors commonly review: Documented CPV procedures and responsibilities … Read more

STATISTICAL TOOLS USED IN CONTINUED PROCESS VERIFICATION (CPV)

by
Continued Process Verification (CPV) dashboard showing pharmaceutical manufacturing process monitoring and statistical trend analysis.

Statistical Tools Used in Continued Process Verification (CPV) A robust Continued Process Verification (CPV) program relies heavily on statistical methods to identify trends, monitor variability, and detect process shifts before they affect product quality. Modern pharmaceutical manufacturers utilize statistical software and data visualization tools to evaluate process performance in real time. 1. Statistical Process Control … Read more

Continued Process Verification (CPV) in Pharma

by
Continued Process Verification (CPV) dashboard showing pharmaceutical manufacturing process monitoring and statistical trend analysis.

Continued Process Verification (CPV) in Pharmaceuticals – Complete Regulatory Guide Continued Process Verification (CPV) in Pharmaceuticals – Complete Regulatory Guide The pharmaceutical industry has evolved significantly from traditional process validation approaches toward a lifecycle-based validation philosophy. One of the most important elements of this lifecycle approach is Continued Process Verification (CPV), which ensures that manufacturing … Read more

Marketing Authorization Approval Process in Europe

by
Marketing Authorization Approval Process in Europe showing EMA review, CTD dossier submission, scientific assessment, and approval workflow.

Marketing Authorization Approval Process in Europe | Complete Guide to EU Pharmaceutical Registration Marketing Authorization Approval Process in Europe: Complete Regulatory Guide Obtaining a Marketing Authorization (MA) is one of the most important milestones in bringing a pharmaceutical product to the European market. Before any medicinal product can be marketed within the European Union (EU) … Read more

Blister Missing Complaints in Pharma

by
Blister Missing Complaints in Pharma: Causes, CAPA & GMP

Blister Missing Complaints in Pharmaceuticals: Root Causes, Investigation & Remedial Actions Blister Missing Complaints in Pharmaceutical Manufacturing: Root Causes, Investigation and Remedial Actions Blister packaging is one of the most widely used packaging systems in the pharmaceutical industry because it provides excellent product protection, enhances patient compliance, and allows easy visual inspection of tablets and … Read more

SUPAC Guidance: Complete FDA Guide to Post-Approval Changes

by
SUPAC Guidance flowchart showing FDA post-approval change categories for pharmaceutical manufacturing.

SUPAC Guidance for Pharmaceutical Industry – Complete FDA Guide to Scale-Up and Post-Approval Changes SUPAC Guidance: A Complete Guide to Scale-Up and Post-Approval Changes in the Pharmaceutical Industry The pharmaceutical industry operates under one of the most stringent regulatory frameworks in the world. After receiving FDA approval, manufacturers often need to make changes to formulations, … Read more

VARIATION FILING IN EUROPE

by

Variation Filing in Europe: A Complete Guide for Pharmaceutical Regulatory Professionals Variation Filing in Europe – Complete Regulatory Guide Once a medicinal product receives marketing authorization in the European Union (EU), its lifecycle does not end. Pharmaceutical companies frequently implement changes to manufacturing processes, analytical methods, packaging materials, manufacturing sites, quality controls, safety information, and … Read more

TYPES OF VARIATION FILING IN USA

by

Types of Variation Filing in USA for Pharma: PAS, CBE-30, CBE-0 & Annual Report | Pharmashare Types of Variation Filing in USA for Pharma: PAS, CBE-30, CBE-0 & Annual Report Explained Last Updated: April 2026 | For: Regulatory Affairs, CMC, QA Professionals If you work in Regulatory Affairs for US FDA submissions, you face this … Read more

483 Observations related to Inadequate Investigations

by

FDA 483 Observations Related to Inadequate Investigations in Pharmaceutical Manufacturing FDA Form 483 Observations Related to Inadequate Investigations in Pharmaceutical Manufacturing In the pharmaceutical industry, investigations are a critical component of the Quality Management System (QMS). Whether dealing with deviations, out-of-specification (OOS) results, customer complaints, environmental monitoring excursions, or product quality defects, a thorough and … Read more

483 Observations on CAPA and CAPA Effectiveness

by

FDA 483 Observations on CAPA & CAPA Effectiveness 2026 | Pharma Compliance Guide FDA 483 Observations on CAPA & CAPA Effectiveness: Why 42% of Warning Letters Quote This Updated: April 21, 2026 | Category: QA & Compliance | Reading Time: 9 min “Corrective and Preventive Action procedures are not adequate.” If you’ve seen a USFDA … Read more